ImmunoRec is a spin-off company of the University of Crete aiming to enter phase-I clinical trial on cancer vaccine personalized therapy (patent ΟΒΙ 20190100297). The novel technology is stated by the National Medicinal Organization as Cancer..
Relevance: 28.75258